LGC, Quality Management and Aquacheck announce joint venture in proficiency testing

01-Sep-2005

LGC has successfully concluded negotiations to form a joint venture focusing on proficiency testing (PT) with Quality Management Limited (QM), and Aquacheck, both independent providers of proficiency testing schemes. The combined operation will encompass over 4000 participating laboratories from across the world to become a major international provider of PT services.

QM provides PT schemes in microbiology and chemistry for the meat, dairy, food, and environmental industries, whilst Aquacheck provides the PT scheme for the water and environmental testing markets. LGC manages a number of PT schemes, covering a varied industry base including brewing, distilling, food, environment, forensic and consumer safety (e.g. toys). The established PT schemes of the joint venture are recognised as essential tools in demonstrating laboratory competence, and are all accredited by the United Kingdom Accreditation Service (UKAS).

PT schemes enable laboratories to monitor and improve analytical measurements by providing an external quality assessment system to complement their own internal quality control processes. Participation in a PT scheme is integral to laboratory accreditation and often supports regulatory requirements, such as the UK Environment Agency's Monitoring Certification Scheme (MCERTS).

Both Dr John Mason, Director of Corporate Development at LGC, and Antony Meier, Chairman of QM, become directors of the joint venture holding company, which will be based in Bury, Lancashire, at the facilities of QM and Aquacheck. Customers have been advised that the running of current schemes will remain unchanged and future plans for the joint venture include working closely with PT scheme steering committees.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Aignostics Raises €14m Series A to Advance AI-powered Pathology - Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases

Aignostics Raises €14m Series A to Advance AI-powered Pathology - Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases

New Clues to Mechanism for "Colossal Resistance" Effects - Understanding could lead to lower-power, increased-memory data-storage devices

New Clues to Mechanism for "Colossal Resistance" Effects - Understanding could lead to lower-power, increased-memory data-storage devices

Researchers uncover new water monitoring technique - New method simultaneously monitors clumps and the mixing intensity in a single step

Researchers uncover new water monitoring technique - New method simultaneously monitors clumps and the mixing intensity in a single step

Researchers use light to detect Alzheimer's - New technique may help identify ways to predict and prevent deadly disease

A breakthrough for organic reactions in water

World record broken for thinnest X-ray detector ever created - Highly sensitive and with a rapid response time, the new X-ray detector is less than 10 nanometres thick and could one day lead to real-time imaging of cellular biology

World record broken for thinnest X-ray detector ever created - Highly sensitive and with a rapid response time, the new X-ray detector is less than 10 nanometres thick and could one day lead to real-time imaging of cellular biology

Why some people with brain markers of Alzheimer’s have no dementia

New detector sniffs out origins of methane - Instrument identifies methane's origins in mines, deep-sea vents, and cows

IChemE and BP publish new animated safety lessons

Caliper Creates Specialized ACES Team to Deliver Customized Technology Solutions - Initiative to Deliver Best-In-Class Solutions for Laboratory Automation

2012 Nobel Prize in Chemistry Uses Research Equipment Engineered Locally from BMG LABTECH

Cellular Communication Agent - Tracking the NO signaling pathway

Cellular Communication Agent - Tracking the NO signaling pathway